MICHAEL GOODMAN: Open Payments
NPI 1992770044 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154 in 7 payments from 5 companies in 2025. Trend: 2023 $106 · 2024 $95 · 2025 $154
Food & beverage: $154
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 2 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: Azstarys, CAPLYTA, Qelbree, VRAYLAR, Jornay PM.
Industry payments across NE — which companies pay providers there.
